Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Perineal Cyst in Transgender Men: A Rare Complication Following Gender Affirming Surgery - A Case Series and Literature Overview.

Sexual medicine

Asseler JD, Ronkes BL, Groenman FA, de Leeuw R, Pigot GLS, van Mello NM.
PMID: 34348219
Sex Med. 2021 Oct;9(5):100415. doi: 10.1016/j.esxm.2021.100415. Epub 2021 Aug 01.

INTRODUCTION: Genital gender affirming surgery (gGAS) is usually the final stage in the medical transition for transgender men and consists of creating a neophallus and neo-scrotum, with or without urethral lengthening(UL). To reduce the complication risks of UL, a...

Cite
Asseler JD, Ronkes BL, Groenman FA, et al. Perineal Cyst in Transgender Men: A Rare Complication Following Gender Affirming Surgery - A Case Series and Literature Overview. Sex Med. 2021;9(5):100415doi: 10.1016/j.esxm.2021.100415.
Asseler, J. D., Ronkes, B. L., Groenman, F. A., de Leeuw, R., Pigot, G. L. S., & van Mello, N. M. (2021). Perineal Cyst in Transgender Men: A Rare Complication Following Gender Affirming Surgery - A Case Series and Literature Overview. Sexual medicine, 9(5), 100415. https://doi.org/10.1016/j.esxm.2021.100415
Asseler, Joyce D, et al. "Perineal Cyst in Transgender Men: A Rare Complication Following Gender Affirming Surgery - A Case Series and Literature Overview." Sexual medicine vol. 9,5 (2021): 100415. doi: https://doi.org/10.1016/j.esxm.2021.100415
Asseler JD, Ronkes BL, Groenman FA, de Leeuw R, Pigot GLS, van Mello NM. Perineal Cyst in Transgender Men: A Rare Complication Following Gender Affirming Surgery - A Case Series and Literature Overview. Sex Med. 2021 Oct;9(5):100415. doi: 10.1016/j.esxm.2021.100415. Epub 2021 Aug 01. PMID: 34348219; PMCID: PMC8498948.
Copy Download .nbib Format: NLM
Combining total laparoscopic hysterectomy and bilateral salpingo-oophorectomy with subcutaneous mastectomy in trans men: The effect on safety outcomes.

International journal of transgender health

Elfering L, van de Grift TC, Bouman MB, van Mello NM, Groenman FA, Huirne JA, Budiman IYW, Goijen LDJ, van Loenen DKG, Mullender MG.
PMID: 33015665
Int J Transgend Health. 2020 Apr 25;21(2):138-146. doi: 10.1080/26895269.2020.1751014. eCollection 2020.

No abstract available.

Cite
Elfering L, van de Grift TC, Bouman MB, et al. Combining total laparoscopic hysterectomy and bilateral salpingo-oophorectomy with subcutaneous mastectomy in trans men: The effect on safety outcomes. Int J Transgend Health. 2020;21(2):138-146doi: 10.1080/26895269.2020.1751014.
Elfering, L., van de Grift, T. C., Bouman, M. B., van Mello, N. M., Groenman, F. A., Huirne, J. A., Budiman, I. Y. W., Goijen, L. D. J., van Loenen, D. K. G., & Mullender, M. G. (2020). Combining total laparoscopic hysterectomy and bilateral salpingo-oophorectomy with subcutaneous mastectomy in trans men: The effect on safety outcomes. International journal of transgender health, 21(2), 138-146. https://doi.org/10.1080/26895269.2020.1751014
Elfering, Lian, et al. "Combining total laparoscopic hysterectomy and bilateral salpingo-oophorectomy with subcutaneous mastectomy in trans men: The effect on safety outcomes." International journal of transgender health vol. 21,2 (2020): 138-146. doi: https://doi.org/10.1080/26895269.2020.1751014
Elfering L, van de Grift TC, Bouman MB, van Mello NM, Groenman FA, Huirne JA, Budiman IYW, Goijen LDJ, van Loenen DKG, Mullender MG. Combining total laparoscopic hysterectomy and bilateral salpingo-oophorectomy with subcutaneous mastectomy in trans men: The effect on safety outcomes. Int J Transgend Health. 2020 Apr 25;21(2):138-146. doi: 10.1080/26895269.2020.1751014. eCollection 2020. PMID: 33015665; PMCID: PMC7430461.
Copy Download .nbib Format: NLM
Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women.

Human reproduction (Oxford, England)

de Nie I, Mulder CL, Meißner A, Schut Y, Holleman EM, van der Sluis WB, Hannema SE, den Heijer M, Huirne J, van Pelt AMM, van Mello NM.
PMID: 34791270
Hum Reprod. 2021 Nov 13; doi: 10.1093/humrep/deab240. Epub 2021 Nov 13.

STUDY QUESTION: Can transgender women cryopreserve germ cells obtained from their orchiectomy specimen for fertility preservation, after having used puberty suppression and/or hormonal treatment?SUMMARY ANSWER: In the vast majority of transgender women, there were still immature germ cells present...

Cite
de Nie I, Mulder CL, Meißner A, et al. Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women. Hum Reprod. 2021;doi: 10.1093/humrep/deab240.
de Nie, I., Mulder, C. L., Meißner, A., Schut, Y., Holleman, E. M., van der Sluis, W. B., Hannema, S. E., den Heijer, M., Huirne, J., van Pelt, A. M. M., & van Mello, N. M. (2021). Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women. Human reproduction (Oxford, England), . https://doi.org/10.1093/humrep/deab240
de Nie, I, et al. "Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women." Human reproduction (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/humrep/deab240
de Nie I, Mulder CL, Meißner A, Schut Y, Holleman EM, van der Sluis WB, Hannema SE, den Heijer M, Huirne J, van Pelt AMM, van Mello NM. Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women. Hum Reprod. 2021 Nov 13; doi: 10.1093/humrep/deab240. Epub 2021 Nov 13. PMID: 34791270.
Copy Download .nbib Format: NLM
Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study.

BJU international

de Nie I, Wiepjes CM, de Blok CJM, van Moorselaar RJA, Pigot GLS, van der Sluis TM, Barbé E, van der Voorn P, van Mello NM, Huirne J, den Heijer M.
PMID: 34390620
BJU Int. 2021 Aug 14; doi: 10.1111/bju.15575. Epub 2021 Aug 14.

OBJECTIVE: To assess the incidence of testicular cancer in trans women (male sex assigned at birth, female gender identity) using gender-affirming hormonal treatment.PATIENTS AND METHODS: Data of trans women starting hormonal treatment at our gender identity clinic between 1972...

Cite
de Nie I, Wiepjes CM, de Blok CJM, et al. Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study. BJU Int. 2021;doi: 10.1111/bju.15575.
de Nie, I., Wiepjes, C. M., de Blok, C. J. M., van Moorselaar, R. J. A., Pigot, G. L. S., van der Sluis, T. M., Barbé, E., van der Voorn, P., van Mello, N. M., Huirne, J., & den Heijer, M. (2021). Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study. BJU international, . https://doi.org/10.1111/bju.15575
de Nie, Iris, et al. "Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study." BJU international vol. (2021). doi: https://doi.org/10.1111/bju.15575
de Nie I, Wiepjes CM, de Blok CJM, van Moorselaar RJA, Pigot GLS, van der Sluis TM, Barbé E, van der Voorn P, van Mello NM, Huirne J, den Heijer M. Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study. BJU Int. 2021 Aug 14; doi: 10.1111/bju.15575. Epub 2021 Aug 14. PMID: 34390620.
Copy Download .nbib Format: NLM
Purging human ovarian cortex of contaminating leukaemic cells by targeting the mitotic catastrophe signalling pathway.

Journal of assisted reproduction and genetics

Eijkenboom L, Mulder C, van der Reijden B, van Mello N, van Leersum J, Koorenhof-Scheele T, Braat D, Beerendonk C, Peek R.
PMID: 33725274
J Assist Reprod Genet. 2021 Jun;38(6):1571-1588. doi: 10.1007/s10815-021-02081-9. Epub 2021 Mar 16.

PURPOSE: Is it possible to eliminate metastasised chronic myeloid leukaemia (CML) and acute myeloid leukaemia (AML) cells from ovarian cortex fragments by inhibition of Aurora B/C kinases (AURKB/C) without compromising ovarian tissue or follicles?METHODS: Human ovarian cortex tissue with...

Cite
Eijkenboom L, Mulder C, van der Reijden B, et al. Purging human ovarian cortex of contaminating leukaemic cells by targeting the mitotic catastrophe signalling pathway. J Assist Reprod Genet. 2021;38(6):1571-1588doi: 10.1007/s10815-021-02081-9.
Eijkenboom, L., Mulder, C., van der Reijden, B., van Mello, N., van Leersum, J., Koorenhof-Scheele, T., Braat, D., Beerendonk, C., & Peek, R. (2021). Purging human ovarian cortex of contaminating leukaemic cells by targeting the mitotic catastrophe signalling pathway. Journal of assisted reproduction and genetics, 38(6), 1571-1588. https://doi.org/10.1007/s10815-021-02081-9
Eijkenboom, Lotte, et al. "Purging human ovarian cortex of contaminating leukaemic cells by targeting the mitotic catastrophe signalling pathway." Journal of assisted reproduction and genetics vol. 38,6 (2021): 1571-1588. doi: https://doi.org/10.1007/s10815-021-02081-9
Eijkenboom L, Mulder C, van der Reijden B, van Mello N, van Leersum J, Koorenhof-Scheele T, Braat D, Beerendonk C, Peek R. Purging human ovarian cortex of contaminating leukaemic cells by targeting the mitotic catastrophe signalling pathway. J Assist Reprod Genet. 2021 Jun;38(6):1571-1588. doi: 10.1007/s10815-021-02081-9. Epub 2021 Mar 16. PMID: 33725274; PMCID: PMC8266964.
Copy Download .nbib Format: NLM
A cohort study on factors impairing semen quality in transgender women.

American journal of obstetrics and gynecology

de Nie I, Asseler J, Meißner A, Voorn-de Warem IAC, Kostelijk EH, den Heijer M, Huirne J, van Mello NM.
PMID: 34688596
Am J Obstet Gynecol. 2021 Oct 22; doi: 10.1016/j.ajog.2021.10.020. Epub 2021 Oct 22.

BACKGROUND: Transgender women (people assigned male genders at birth with female gender identities) can choose to cryopreserve semen before their medical transition, to retain the possibility to parent genetically related offspring later in life. Our previous retrospective study showed...

Cite
de Nie I, Asseler J, Meißner A, et al. A cohort study on factors impairing semen quality in transgender women. Am J Obstet Gynecol. 2021;doi: 10.1016/j.ajog.2021.10.020.
de Nie, I., Asseler, J., Meißner, A., Voorn-de Warem, I. A. C., Kostelijk, E. H., den Heijer, M., Huirne, J., & van Mello, N. M. (2021). A cohort study on factors impairing semen quality in transgender women. American journal of obstetrics and gynecology, . https://doi.org/10.1016/j.ajog.2021.10.020
de Nie, Iris, et al. "A cohort study on factors impairing semen quality in transgender women." American journal of obstetrics and gynecology vol. (2021). doi: https://doi.org/10.1016/j.ajog.2021.10.020
de Nie I, Asseler J, Meißner A, Voorn-de Warem IAC, Kostelijk EH, den Heijer M, Huirne J, van Mello NM. A cohort study on factors impairing semen quality in transgender women. Am J Obstet Gynecol. 2021 Oct 22; doi: 10.1016/j.ajog.2021.10.020. Epub 2021 Oct 22. PMID: 34688596.
Copy Download .nbib Format: NLM
Feasibility study for performing uterus transplantation in the Netherlands.

Human reproduction open

Peters HE, Juffermans LJM, Lambalk CB, Dekker JJML, Fernhout T, Groenman FA, de Groot CJM, Hoksbergen AWJ, Huirne JAF, de Leeuw RA, van Mello NM, Nederhoed JH, Schats R, Verhoeven MO, Hehenkamp WJK.
PMID: 32128452
Hum Reprod Open. 2020 Feb 28;2020(2):hoz032. doi: 10.1093/hropen/hoz032. eCollection 2020.

STUDY QUESTION: Is it feasible to perform uterus transplantations (UTx) in a tertiary centre in the Netherlands?SUMMARY ANSWER: Considering all ethical principles, surgical risks and financial aspects, we have concluded that at this time, it is not feasible to...

Cite
Peters HE, Juffermans LJM, Lambalk CB, et al. Feasibility study for performing uterus transplantation in the Netherlands. Hum Reprod Open. 2020;2020(2):hoz032doi: 10.1093/hropen/hoz032.
Peters, H. E., Juffermans, L. J. M., Lambalk, C. B., Dekker, J. J. M. L., Fernhout, T., Groenman, F. A., de Groot, C. J. M., Hoksbergen, A. W. J., Huirne, J. A. F., de Leeuw, R. A., van Mello, N. M., Nederhoed, J. H., Schats, R., Verhoeven, M. O., & Hehenkamp, W. J. K. (2020). Feasibility study for performing uterus transplantation in the Netherlands. Human reproduction open, 2020(2), hoz032. https://doi.org/10.1093/hropen/hoz032
Peters, H E, et al. "Feasibility study for performing uterus transplantation in the Netherlands." Human reproduction open vol. 2020,2 (2020): hoz032. doi: https://doi.org/10.1093/hropen/hoz032
Peters HE, Juffermans LJM, Lambalk CB, Dekker JJML, Fernhout T, Groenman FA, de Groot CJM, Hoksbergen AWJ, Huirne JAF, de Leeuw RA, van Mello NM, Nederhoed JH, Schats R, Verhoeven MO, Hehenkamp WJK. Feasibility study for performing uterus transplantation in the Netherlands. Hum Reprod Open. 2020 Feb 28;2020(2):hoz032. doi: 10.1093/hropen/hoz032. eCollection 2020. PMID: 32128452; PMCID: PMC7048682.
Copy Download .nbib Format: NLM
Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam.

The British journal of surgery

van der Sluis WB, de Nie I, Steensma TD, van Mello NM, Lissenberg-Witte BI, Bouman MB.
PMID: 34291277
Br J Surg. 2021 Dec 17;109(1):8-11. doi: 10.1093/bjs/znab213.

No abstract available.

Cite
van der Sluis WB, de Nie I, Steensma TD, et al. Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam. Br J Surg. 2021;109(1):8-11doi: 10.1093/bjs/znab213.
van der Sluis, W. B., de Nie, I., Steensma, T. D., van Mello, N. M., Lissenberg-Witte, B. I., & Bouman, M. B. (2021). Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam. The British journal of surgery, 109(1), 8-11. https://doi.org/10.1093/bjs/znab213
van der Sluis, W B, et al. "Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam." The British journal of surgery vol. 109,1 (2021): 8-11. doi: https://doi.org/10.1093/bjs/znab213
van der Sluis WB, de Nie I, Steensma TD, van Mello NM, Lissenberg-Witte BI, Bouman MB. Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam. Br J Surg. 2021 Dec 17;109(1):8-11. doi: 10.1093/bjs/znab213. PMID: 34291277.
Copy Download .nbib Format: NLM
Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam.

The British journal of surgery

van der Sluis WB, de Nie I, Steensma TD, van Mello NM, Lissenberg-Witte BI, Bouman MB.
PMID: 34291277
Br J Surg. 2021 Dec 17;109(1):8-11. doi: 10.1093/bjs/znab213.

No abstract available.

Cite
van der Sluis WB, de Nie I, Steensma TD, et al. Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam. Br J Surg. 2021;109(1):8-11doi: 10.1093/bjs/znab213.
van der Sluis, W. B., de Nie, I., Steensma, T. D., van Mello, N. M., Lissenberg-Witte, B. I., & Bouman, M. B. (2021). Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam. The British journal of surgery, 109(1), 8-11. https://doi.org/10.1093/bjs/znab213
van der Sluis, W B, et al. "Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam." The British journal of surgery vol. 109,1 (2021): 8-11. doi: https://doi.org/10.1093/bjs/znab213
van der Sluis WB, de Nie I, Steensma TD, van Mello NM, Lissenberg-Witte BI, Bouman MB. Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam. Br J Surg. 2021 Dec 17;109(1):8-11. doi: 10.1093/bjs/znab213. PMID: 34291277.
Copy Download .nbib Format: NLM
Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients.

Pragmatic and observational research

Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, Halpin DMG, Hickman K, Pinnock H, Quint JK, Khunti K, Heaney LG, Oliver P, Siddiqui S, Pavord I, Jones DHM, Hyland M, Ritchie L, Young P, Megaw T, Davis S, Walker S, Holgate S, Beecroft S, Kemppinen A, Appiagyei F, Roberts EJ, Preston M, Hardjojo A, Carter V, van Melle M, Price D.
PMID: 34408531
Pragmat Obs Res. 2021 Aug 11;12:93-104. doi: 10.2147/POR.S316186. eCollection 2021.

INTRODUCTION: Symptoms may persist after the initial phases of COVID-19 infection, a phenomenon termed long COVID. Current knowledge on long COVID has been mostly derived from test-confirmed and hospitalized COVID-19 patients. Data are required on the burden and predictors...

Cite
Jones R, Davis A, Stanley B, et al. Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients. Pragmat Obs Res. 2021;12:93-104doi: 10.2147/POR.S316186.
Jones, R., Davis, A., Stanley, B., Julious, S., Ryan, D., Jackson, D. J., Halpin, D. M. G., Hickman, K., Pinnock, H., Quint, J. K., Khunti, K., Heaney, L. G., Oliver, P., Siddiqui, S., Pavord, I., Jones, D. H. M., Hyland, M., Ritchie, L., Young, P., Megaw, T., Davis, S., Walker, S., Holgate, S., Beecroft, S., Kemppinen, A., Appiagyei, F., Roberts, E. J., Preston, M., Hardjojo, A., Carter, V., van Melle, M., & Price, D. (2021). Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients. Pragmatic and observational research, 1293-104. https://doi.org/10.2147/POR.S316186
Jones, Rupert, et al. "Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients." Pragmatic and observational research vol. 12 (2021): 93-104. doi: https://doi.org/10.2147/POR.S316186
Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, Halpin DMG, Hickman K, Pinnock H, Quint JK, Khunti K, Heaney LG, Oliver P, Siddiqui S, Pavord I, Jones DHM, Hyland M, Ritchie L, Young P, Megaw T, Davis S, Walker S, Holgate S, Beecroft S, Kemppinen A, Appiagyei F, Roberts EJ, Preston M, Hardjojo A, Carter V, van Melle M, Price D. Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients. Pragmat Obs Res. 2021 Aug 11;12:93-104. doi: 10.2147/POR.S316186. eCollection 2021. PMID: 34408531; PMCID: PMC8366779.
Copy Download .nbib Format: NLM
Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam.

The British journal of surgery

van der Sluis WB, de Nie I, Steensma TD, van Mello NM, Lissenberg-Witte BI, Bouman MB.
PMID: 34291277
Br J Surg. 2021 Jul 19; doi: 10.1093/bjs/znab213. Epub 2021 Jul 19.

No abstract available.

Cite
van der Sluis WB, de Nie I, Steensma TD, et al. Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam. Br J Surg. 2021;doi: 10.1093/bjs/znab213.
van der Sluis, W. B., de Nie, I., Steensma, T. D., van Mello, N. M., Lissenberg-Witte, B. I., & Bouman, M. B. (2021). Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam. The British journal of surgery, . https://doi.org/10.1093/bjs/znab213
van der Sluis, W B, et al. "Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam." The British journal of surgery vol. (2021). doi: https://doi.org/10.1093/bjs/znab213
van der Sluis WB, de Nie I, Steensma TD, van Mello NM, Lissenberg-Witte BI, Bouman MB. Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam. Br J Surg. 2021 Jul 19; doi: 10.1093/bjs/znab213. Epub 2021 Jul 19. PMID: 34291277.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries